Global Nanomedicine market to grow at a CAGR of 12.57 percent over the period 2012-2016. One of the key factors contributing to this market growth is the emergence of nanorobotics. The Global Nanomedicine market has also been witnessing the increasing use of novel nanomaterials. However, lengthy approval procedures could pose a challenge to the growth of this market.
View Full Report With TOC@ http://www.researchmoz.us/global-nanomedicine-market-2012-2016-report.html
Global Nanomedicine Market 2012-2016: Industry Analysis, Size, Share, Trends And Forecast Research Report
1. Global Nanomedicine Market 2012-2016
TechNavio's analysts forecast the Global Nanomedicine market to grow at a CAGR of 12.57 percent over the
period 2012-2016. One of the key factors contributing to this market growth is the emergence of nanorobotics.
The Global Nanomedicine market has also been witnessing the increasing use of novel nanomaterials.
However, lengthy approval procedures could pose a challenge to the growth of this market.
TechNavio's report, the Global Nanomedicine Market 2012-2016, has been prepared based on an in-depth
market analysis with inputs from industry experts. The report covers the market in the Americas, and the
EMEA and APAC regions; it also covers the Global Nanomedicine market landscape and its growth prospects
in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Abbott Laboratories, AstraZeneca plc, Bristol-Myers Squibb
Co., Celgene Corp., GlaxoSmithKline plc, and Pfizer Inc.
The other vendors mentioned in this report are Ablynx NV, Acusphere Inc., Aphios Corp., Arrowhead
Research Corp., BioForce, Nanosciences Holdings Inc., Bio-Gate AG, Biophan Technologies Inc., BioSante
Pharmaceuticals Inc., CombiMatrix Corp., Enzon Pharmaceuticals Inc., GE Healthcare Ltd., Gilead Sciences
Inc., IDEX Corp., IGI Laboratories Inc., Kereos Inc., Kimberly-Clark Corp., MIV Therapeutics Inc.,
Nanobiotix S.A., NanoCarrier Co. Ltd., Nanogen Inc., NanoLogix Inc., NanoMed Pharmaceuticals Inc.,
Nanotherapeutics Inc., NanoViricides Inc., Paladin Labs Inc., pSivida Corp., Qiagen N.V., Roche Holding
AG, Skyepharma PLC, Smith & Nephew plc, Starpharma Holdings Ltd., Stryker Corp., and Tecan Group
Ltd.
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate? What are key market trends? What is
driving this market? What are the challenges to market growth? Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors? What are the strengths and weaknesses of
each of these key vendors?
table Of Content
1. Executive Summary
2. List Of Abbreviations
3. Introduction
4. Market Research Methodology
market Research Process
Global Nanomedicine Market 2012-2016
2. research Design
research Methodology
5. Scope Of The Report
market Overview
product Offerings
6. Market Landscape
6.1 Global Nanotechnology Market
market Overview
6.2 Global Nanomedicine Market
market Size And Forecast
6.3 Five Forces Analysis
7. Key Market Segmentation
7.1 Segmentation By Application
7.2 Global Nanomedicine Market In Anticancer Applications
market Size And Forecast
7.3 Global Nanomedicine Market In Cns Applications
market Size And Forecast
7.4 Global Nanomedicine Market In Anti-infective Application
market Size And Forecast
7.5 Global Nanomedicine Market In Anti-inflammatory Application
market Size And Forecast
7.6 Global Nanomedicine Market In Cardiovascular Application
market Size And Forecast
7.7 Global Nanomedicine Market In Other Applications
market Size And Forecast
8. Geographical Segmentation
9. Key Leading Countries
usa
germany
japan
10. Vendor Landscape
Global Nanomedicine Market 2012-2016
3. 11. Buying Criteria
12. Market Growth Drivers
13. Drivers And Their Impact
14. Market Challenges
15. Impact Of Drivers And Challenges
16. Market Trends
17. Key Vendor Analysis
17.1 Abbott Laboratories
business Overview
key Information
swot Analysis
17.2 Astrazeneca Plc
business Overview
key Information
swot Analysis
17.3 Bristol-myers Squibb Co.
business Overview
key Information
swot Analysis
17.4 Celgene Corp.
business Overview
key Information
swot Analysis
17.5 Glaxosmithkline Plc
business Overview
key Information
swot Analysis
17.6 Pfizer Inc.
business Overview
Global Nanomedicine Market 2012-2016
4. key Information
swot Analysis
18. Other Reports In This Series
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Global Nanomedicine Market 2012-2016